Company Search:
Advanced Search
Sponsored Links
Acadia Pharmaceuticals, Inc. Company Snapshot
Acadia Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acadia Pharmaceuticals with three other companies in this sector in the United States: RegeneRx Biopharmaceuticals, Inc. (2015 sales of $60,612.00 ), Cocrystal Pharma Inc ($78,000.00 ), and Endocyte, Inc. ($70,000.00 ).

Sales Analysis. Acadia Pharmaceuticals reported sales of $61,000.00 for the year ending December of 2015. This represents a sharp decrease of 49.2% versus 2014, when the company's sales were $120,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acadia Pharmaceuticals, Inc.
  Stock Performance Chart for Acadia Pharmaceuticals, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 31.02
(Figures in U.S. Dollars)
1 Week -2.4%   13 Weeks 4.3%  
4 Weeks 22.4%   52 Weeks 26.5%  
Acadia Pharmaceuticals, Inc. Key Data:
  Ticker: ACAD Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 61,000
(Year Ending Jan 2016).
Employees: 160
  Currency: U.S. Dollars Market Cap: 3,756,951,503
  Fiscal Yr Ends: December Shares Outstanding: 121,113,846
  Share Type: Common Closely Held Shares: 263,416
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.